HAVN Life Sciences Inc (OTCMKTS:HAVLF) is a brand new public company with a mission to be the future of psychedelic medicine. The shroom boom is in full effect, so we sat down to talk about how HAVN is differentiating itself within this emerging space. Former Aphria Inc (NASDAQ:APHA) CEO, former Jamieson Wellness Inc (TSE:JWEL) CEO, and now HAVN […]